Artelo Biosciences
ARTL
5 hedge funds and large institutions have $36.6K invested in Artelo Biosciences in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
43% more capital invested
Capital invested by funds: $25.6K → $36.6K (+$10.9K)
25% more funds holding
Funds holding: 4 → 5 (+1)
0.02% more ownership
Funds ownership: 0.04% → 0.06% (+0.02%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.53K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Geode Capital Management
Boston,
Massachusetts
| $18.4K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $14.1K | +$14.9K | +739 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $4.05K | -$1.53K | -76 | -26% |
|
4
Bank of America
Charlotte,
North Carolina
| $28 | – | – | – |
|
5
Morgan Stanley
New York
| $21 | – | – | – |
|
|
RIL
6
Rothschild Investment LLC
Chicago,
Illinois
| $8 | – | – | – |
|
ARTL Hedge Fund Activity: Q4 2024 in Review
5 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q4 2024, worth a combined $36.6K — up 43% from $25.6K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARTL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $14.9K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.53K.
- 5 institutional investors held Artelo Biosciences (ARTL) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $36.6K of Artelo Biosciences stock for Q4 2024, up 43% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest Artelo Biosciences buyer in Q4 2024 was UBS Group, an estimated $14.9K added.
- The largest Artelo Biosciences seller in Q4 2024 was Tower Research Capital (TRC), an estimated $1.53K sold.
Based on aggregated 13F filings for Q4 2024.